Search clinical trials for: OT-551
Total 1045 results
-
AVEO Pharmaceuticals, Inc.CompletedFood Effect of Tivozanib in Health SubjectsUnited States
-
Chong Kun Dang PharmaceuticalCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAlzheimer DiseaseUnited States
-
Icahn School of Medicine at Mount SinaiRecruitingBorderline Personality DisorderUnited States
-
AmgenRecruitingAtopic DermatitisUnited States
-
Merck Sharp & Dohme LLCRecruitingNon-Hodgkins Lymphoma | Hematologic Malignancies | Chronic Lymphocytic Leukaemia | Waldenstroms MacroglobulinaemiaPoland, United States, Argentina, Australia, Brazil, Canada, France, Israel, Italy, Spain, Switzerland, Turkey, United Kingdom, Korea, Republic of, Germany, Denmark, China, Romania, Czechia, Hungary, Ireland, Ukraine
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
AVEO Pharmaceuticals, Inc.CompletedColorectal Cancer | Gastrointestinal CancerNetherlands
-
Beacon TherapeuticsEnrolling by invitationX-Linked Retinitis PigmentosaUnited States
-
Bellicum PharmaceuticalsTerminatedHemoglobinopathies | Hemophagocytic Lymphohistiocytosis | Metabolic Disorders | Primary Immune Deficiency Disorders | Inherited Bone Marrow Failure SyndromeUnited States
-
Neurotech PharmaceuticalsThe Lowy Medical Research Institute LimitedCompletedMacular Telangiectasia Type 2United States, Australia
-
AmgenCompletedIdiopathic Thrombocytopenic PurpuraItaly, United States, Germany, Czechia, United Kingdom, Australia, Spain, Poland, France
-
Millendo Therapeutics SASTerminatedHyperphagia | Prader-Willi SyndromeUnited States, Belgium, Spain, France, Italy, United Kingdom, Australia, Netherlands
-
Bellicum PharmaceuticalsWithdrawnHematologic MalignanciesUnited States
-
MedImmune LLCAmgenCompletedPrimary Sjögren's SyndromeUnited States, Sweden, France, United Kingdom
-
AbbVieCompletedMultiple SclerosisUnited States
-
Columbia UniversityNational Institute on Aging (NIA)WithdrawnDiabetes Mellitus | Alzheimer DementiaUnited States
-
Neurotech PharmaceuticalsCompletedRetinitis PigmentosaUnited States
-
Jeffrey L GoldbergCompletedGlaucoma, Primary Open AngleUnited States
-
Boehringer IngelheimCompleted
-
Rapa Therapeutics LLCHackensack Meridian HealthTerminated
-
Dr Lim Siu MinRecruitingTremor | Temperature Change, Body | Nausea, Postoperative | Vomiting, Postoperative | Postoperative Shivering | ChillsMalaysia
-
Azitra Inc.Not yet recruiting
-
Mitsubishi Tanabe Pharma CorporationRecruiting
-
Apollomics (Australia) Pty. Ltd.Novotech (Australia) Pty Limited; Apollomics Inc. (formerly CBT Pharmaceuticals...CompletedSolid Tumor | Microsatellite Instability | Mismatch Repair Deficiency | Cancer of Unknown Primary SiteAustralia
-
Jae Seung KimSamsung Medical Center; Korea Health Industry Development InstituteCompletedNeurodegenerative Diseases | Mild Cognitive Impairment | Alzheimer's DiseaseKorea, Republic of
-
Asan FoundationCompletedAlzheimer DiseaseKorea, Republic of
-
AmgenCompletedLupus Arthritis, Systemic Lupus ErythematosusUnited States, Taiwan, Germany, Denmark, Australia, United Kingdom, Malaysia, France
-
Neurotech PharmaceuticalsCompletedRetinitis PigmentosaUnited States
-
Jeffrey L GoldbergCompletedIschemic Optic Neuropathy/Optic Nerve StrokeUnited States
-
Hoya Surgical Optics, Inc.Completed
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
AmgenTerminated
-
PfizerCompletedUlcerative ColitisBrazil, Hungary, Belgium, Czech Republic, Italy, South Africa, Spain, United Kingdom, Sweden, Slovakia, Denmark, Poland, France, Chile, Israel, Mexico, Netherlands
-
Rapa Therapeutics LLCMassachusetts General Hospital; Hackensack Meridian HealthRecruiting
-
Oncotelic Inc.Not yet recruiting
-
MedImmune LLCCompletedCancer | B-cell MalignanciesUnited States, Italy, Belgium, Canada, Spain
-
Aclaris Therapeutics, Inc.Completed
-
Edgewood Oncology Inc.RecruitingMetastatic Breast Cancer | Advanced Solid TumorUnited States
-
Chong Kun Dang PharmaceuticalRecruitingEfficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 DiabetesType2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 DiabetesKorea, Republic of
-
Arcutis Biotherapeutics, Inc.CompletedMaximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)Psoriasis | Plaque PsoriasisUnited States, Canada, Dominican Republic
-
Chong Kun Dang PharmaceuticalCompletedType2 Diabetes MellitusKorea, Republic of
-
Dermavant Sciences GmbHCompletedAtopic DermatitisUnited States, Canada
-
RespiralabNot yet recruiting
-
Rapa Therapeutics LLCMassachusetts General Hospital; Hackensack Meridian HealthAvailable
-
Bellicum PharmaceuticalsTerminatedLymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Primary Immunodeficiency | Anemia, Sickle Cell | Hemoglobinopathies | Fanconi Anemia | Anemia, Aplastic | Thalassemia | Cytopenia | Diamond Blackfan Anemia | Leukemia, Acute Myeloid (AML), ChildItaly